美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioVentrix Inc

成交量：- -

成交额：- -

市值：- -

市盈率：- -

高：- -

开：- -

低：- -

收：- -

52周最高：- -

52周最低：- -

股本：- -

流通股本：- -

量比：- -

换手率：- -

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：-134.03%

市净率：0.00

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

BioVentrix Inc

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.bioventrix.com

邮编：

- -

电话：

- -

传真：

- -

简介：

BioVentrix, Inc.是一家特拉华州公司，最初于2003年10月15日在加利福尼亚州注册成立为CHF Technologies，Inc.，并于2012年6月8日在特拉华州重新注册成立。该公司是一家医疗器械公司，专注于开发、制造和商业化专有设备，以恢复射血分数降低的心力衰竭患者的左心室功能。其主导项目Revivent System在欧洲获得CE标志，目前正在美国进行关键试验。该公司还持有Alginate的所有权，这是一种基于水凝胶的设备，用于治疗没有前道瘢痕的HFREF患者。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BVXX/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BVXX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BVXX\",,,,,undefined,":{"symbol":"BVXX","market":"US","secType":"STK","nameCN":"BioVentrix Inc","latestPrice":0,"timestamp":1780948800000,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0,"latestTime":"06-08 16:00:00 EDT","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1780992000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BVXX\",,,,,undefined,":{"symbol":"BVXX","floatShares":0,"roa":"-134.03%","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"0.00","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BVXX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BVXX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BVXX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.bioventrix.com","compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioVentrix, Inc.是一家特拉华州公司，最初于2003年10月15日在加利福尼亚州注册成立为CHF Technologies，Inc.，并于2012年6月8日在特拉华州重新注册成立。该公司是一家医疗器械公司，专注于开发、制造和商业化专有设备，以恢复射血分数降低的心力衰竭患者的左心室功能。其主导项目Revivent System在欧洲获得CE标志，目前正在美国进行关键试验。该公司还持有Alginate的所有权，这是一种基于水凝胶的设备，用于治疗没有前道瘢痕的HFREF患者。","exchange":"NASDAQ","name":"BioVentrix Inc","nameEN":"BioVentrix Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BVXX\",market:\"US\",,,undefined,":null}}